| BMI < 25 | BMI 25-30 | BMI > 30 | ||||
| Early (N=3) | Late (N=15) | Early (N=5) | Late (N=24) | Early (N=5) | Late (N=21) | |
| Post-aBD FEV1, % | 77.3±6.6 | 86.2±18.9 | 82±12.5 | 87.9±15.3 | 86.6±23.7 | 86.6±22.0 |
| Sputum eosinophils, % | 53.2 (22.3-84.1) | 51.3 (3.7-93.7) | 9.6 (0.6-17.9) | 12.6 (0-95.6) | 0.9 (0-4.9) | 25.6 (0-71.2)* |
| ACT<20 | 33.3 | 26.7 | 40 | 41.7 | 60 | 77.8 |
| Patients with exacerbations | 66.7 | 54.5 | 60 | 69.6 | 75 | 71.4 |
*p<0.05